Ирска - Енглески - HPRA (Health Products Regulatory Authority)

bayer limited - sodium hydrogen carbonate; aspirin; citric acid anhydrous - effervescent tablet - 324 mg/1744 mg/965 milligram(s) - salicylic acid and derivatives; acetylsalicylic acid

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

bayer plc - acetylsalicylic acid citric acid sodium bicarbonate - tablets - 324 milligram

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

medac gesellschaft fur klinische spezialpraparate - levofolinic acid sodium hydroxide - solution for inj/inf - 50 micromol

Сингапур - Енглески - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - pentoxifylline - tablet, film coated - 400 mg - pentoxifylline 400 mg

Сингапур - Енглески - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - hydroxide polymaltose complex eqv iron - syrup - 10mg/ml - hydroxide polymaltose complex eqv iron 50mg/5ml

Сингапур - Енглески - HSA (Health Sciences Authority)

vifor pharma asia pacific pte. ltd. - iron hydroxide polymaltose eqv iron - solution - 50 mg/ml - iron hydroxide polymaltose eqv iron 50 mg/ml

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

rowex ltd - acetylsalicylic acid - gastro-resistant tablet - 75 milligram(s) - platelet aggregation inhibitors excl. heparin; acetylsalicylic acid - antithrombotic agents: platelet aggregation inhibitors excl. heparin - it is used for: secondary prevention of myocardial infarction, prevention of cardiovascular morbidity in patients suffering from stable angina pectoris, history of unstable angina pectoris, except during the acute phase, prevention of graft occlusion after coronary artery bypass grafting (cabg), coronary angioplasty, except during the acute phase, secondary prevention of transient ischaemic attacks (tia) and ischaemic cerebrovascular accidents (cva), provided intracerebral haemorrhages have been ruled out.

Малта - Енглески - Medicines Authority

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - pentoxifylline - modified-release tablet - pentoxifylline 400 mg - peripheral vasodilators

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - tenoxicam 20mg - film coated tablet - 20 mg - active: tenoxicam 20mg excipient: hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch purified talc   titanium dioxide - reutenox is indicated for the symptomatic treatment of the following painful inflammatory and degenerative disorders of the musculoskeletal system: · rheumatoid arthritis · osteoarthritis · arthrosis · ankylosing spondylitis · extra-articular disorders, e.g. tendinitis, bursitis, periarthritis of shoulders (shoulder-hand syndrome) or hips, strains and sprains · post-operative pain reutenox tablets are also indicated for: · acute gout · primary dysmenorrhea

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - iron polymaltose, quantity: 185 mg/ml (equivalent: iron, qty 50 mg/ml) - oral liquid - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; purified water; sucrose; sodium hydroxide; flavour - treatment of iron deficiency in adults and adolescents where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.,prevention of iron deficiency in adults and adolescents at high risk where the use of ferrous iron supplements is not tolerated, or otherwise inappropriate.